DexCom (DXCM)
(Delayed Data from NSDQ)
$137.87 USD
+3.87 (2.89%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $138.20 +0.33 (0.24%) 7:44 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Average Brokerage Rating
Current ABR | 1.24 |
ABR (Last week) | 1.24 |
# of Recs in ABR | 21 |
Average Target Price | $146.20 |
LT Growth Rate | 33.10% |
Industry | Medical - Instruments |
Industry Rank by ABR | 95 of 252 |
Current Quarter EPS Est: | 0.27 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 18 | 18 | 18 | 18 | 17 |
Buy | 1 | 1 | 1 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.24 | 1.24 | 1.24 | 1.20 | 1.21 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/15/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
1/3/2024 | Raymond James | Jayson T Bedford | Strong Buy | Strong Buy |
12/19/2023 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
10/27/2023 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
10/27/2023 | Canaccord Genuity | William J Plovanic | Not Available | Strong Buy |
10/16/2023 | SVB Securities | Michael Kratky | Not Available | Strong Buy |
7/28/2023 | Robert W. Baird & Co. | Jeffrey D Johnson | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.